Understanding how Ufbp1 regulates antibody-producing cells.
Regulation of antibody secreting cell (ASC) homeostasis by Ufbp1.
This study is looking at a protein called Ufbp1 to see how it helps B cells turn into antibody-making cells, which are important for fighting off infections, and it hopes to use this knowledge to make better vaccines and boost our immune responses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10897883 on NIH RePORTER |
What this research studies
This research investigates the role of Ufbp1 in the development and function of antibody-secreting cells (ASCs), which are crucial for the immune response. It focuses on how Ufbp1 influences the differentiation of B cells into short-lived plasmablasts and long-lived plasma cells, which produce antibodies that protect against pathogens. The study employs structure-function analysis to identify specific regions of Ufbp1 that affect ASC development and function. By understanding these mechanisms, the research aims to improve vaccine design and enhance immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect antibody production or immune responses, such as B-cell deficiencies or autoimmune diseases.
Not a fit: Patients with conditions unrelated to antibody production or those who do not have immune system deficiencies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better vaccines and therapies that enhance the body's ability to produce effective antibodies against infections.
How similar studies have performed: Previous research has shown promising results in understanding the role of molecular mechanisms in immune responses, suggesting that this approach could yield valuable insights.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Singh, Nagendra — Augusta University
- Study coordinator: Singh, Nagendra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.